{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:42:41Z","timestamp":1780562561209,"version":"3.54.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Although depression and chronic pain often coexist, few studies have examined antidepressant use among people with pain. This study examines the prevalence and characteristics associated with antidepressant use among people prescribed opioids for chronic noncancer pain (CNCP).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Baseline data from a prospective cohort study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Australian community.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Subjects<\/jats:title>\n                  <jats:p>A total of 1166 people prescribed opioids for CNCP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Baseline data collection consisted of a self-completed seven-day medication diary and telephone interview to collect information on sociodemographic characteristics and mental\/physical health using validated questionnaires. Logistic regression was used to examine characteristics associated with antidepressant use, reporting adjusted odds ratios (AORs) and 95% confidence intervals (CIs).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 1166 participants, 668 (57.3%) were female, and the median (interquartile range) age was 59 (49\u201368) years. About half the cohort (N\u2009=\u2009637, 54.6%) used antidepressants. Of these, 329 (51.7%) reported moderate to severe depression. Amitriptyline was the most commonly used antidepressant (17.3%). Factors independently associated with antidepressant use were being female (AOR = 1.47, 95% CI = 1.13\u20131.92), more years lived in pain (AOR = 1.01, 95% CI = 1.00\u20131.02), and use of nonopioid analgesics (AOR = 1.34, 95% CI = 1.01\u20131.78), benzodiazepines and related drugs (AOR = 1.84, 95% CI = 1.36\u20132.49), antiepileptics (AOR = 1.86, 95% CI = 1.38\u20132.51), and antipsychotics (AOR = 2.15, 95% CI = 1.22\u20133.77).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Antidepressant use is common among people with CNCP prescribed opioids. Those using antidepressants were more likely to use other psychotropic medicines concurrently, highlighting that they are a high-risk population requiring comprehensive assessment to optimize outcomes and reduce potential harms from polypharmacy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/pm\/pnz009","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T12:45:00Z","timestamp":1547556300000},"page":"2450-2458","source":"Crossref","is-referenced-by-count":18,"title":["Antidepressant Use Among People Prescribed Opioids for Chronic Noncancer Pain"],"prefix":"10.1093","volume":"20","author":[{"given":"Natasa","family":"Gisev","sequence":"first","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, Australia"},{"name":"Monash Addiction Research Centre, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Campbell","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Thomas","family":"Santo","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mant","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimondo","family":"Bruno","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Cohen","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne D","family":"Hall","sequence":"additional","affiliation":[{"name":"Centre for Youth Substance Abuse Research, University of Queensland, Brisbane, Queensland, Australia"},{"name":"National Addiction Centre, Kings College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briony","family":"Larance","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, Australia"},{"name":"School of Psychology, University of Wollongong, Wollongong, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Lintzeris","sequence":"additional","affiliation":[{"name":"Discipline of Addiction Medicine, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"The Langton Centre, South East Sydney Local Health District Drug and Alcohol Services, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, Australia"},{"name":"School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"key":"2021031608590508300_pnz009-B1","volume-title":"eTG Complete: Analgesic","author":"Therapeutic Guidelines Limited","year":"2018"},{"issue":"1","key":"2021031608590508300_pnz009-B2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0004867412466595","article-title":"Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011","volume":"47","author":"Stephenson","year":"2013","journal-title":"Aust N Z J Psychiatry"},{"key":"2021031608590508300_pnz009-B3","volume-title":"eTG Complete: Psychotropic","author":"Therapeutic Guidelines","year":"2018"},{"issue":"2","key":"2021031608590508300_pnz009-B4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00002508-199706000-00006","article-title":"Chronic pain-associated depression: Antecedent or consequence of chronic pain? A review","volume":"13","author":"Fishbain","year":"1997","journal-title":"Clin J Pain"},{"issue":"9","key":"2021031608590508300_pnz009-B5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jpain.2011.03.003","article-title":"Reciprocal relationship between pain and depression: A 12-month longitudinal analysis in primary care","volume":"12","author":"Kroenke","year":"2011","journal-title":"J Pain"},{"issue":"2","key":"2021031608590508300_pnz009-B6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.j.pain.0000460303.63948.8e","article-title":"The pain and opioids IN treatment study: Characteristics of a cohort using opioids to manage chronic non-cancer pain","volume":"156","author":"Campbell","year":"2015","journal-title":"Pain"},{"issue":"11","key":"2021031608590508300_pnz009-B7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/pds.4301","article-title":"The prevalence of pain and analgesia use in the Australian population: Findings from the 2011 to 2012 Australian National Health Survey","volume":"26","author":"Miller","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2\u20133","key":"2021031608590508300_pnz009-B8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3959(00)00355-9","article-title":"Chronic pain in Australia: A prevalence study","volume":"89","author":"Blyth","year":"2001","journal-title":"Pain"},{"key":"2021031608590508300_pnz009-B9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.genhosppsych.2012.06.018","article-title":"Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients","volume":"34","author":"Merril","year":"2012","journal-title":"Gen Hosp Psychiatry"},{"issue":"9","key":"2021031608590508300_pnz009-B10","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/pme.12448","article-title":"Does pain interfere with antidepressant depression treatment response and remission in patients with depression and pain? An evidence-based structured review","volume":"15","author":"Fishbain","year":"2014","journal-title":"Pain Med"},{"issue":"3","key":"2021031608590508300_pnz009-B11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2105\/AJPH.2016.303591","article-title":"Suicide deaths with opioid poisoning in the United States: 1999\u20132014","volume":"107","author":"Braden","year":"2017","journal-title":"Am J Public Health"},{"issue":"5","key":"2021031608590508300_pnz009-B12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5694\/mja10.11450","article-title":"Prescription of opioid analgesics and related harms in Australia","volume":"195","author":"Roxburgh","year":"2011","journal-title":"Med J Aust"},{"key":"2021031608590508300_pnz009-B13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fneur.2017.00307","article-title":"Adverse effects of antidepressants for chronic pain: A systematic review and meta-analysis","volume":"8","author":"Riediger","year":"2017","journal-title":"Front Neurol"},{"key":"2021031608590508300_pnz009-B14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2050-6511-15-17","article-title":"Cohort protocol paper: The Pain and Opioids In Treatment (POINT) study","author":"Campbell","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"2021031608590508300_pnz009-B15","article-title":"The Brief Pain Inventory","author":"Cleeland","year":"1991","journal-title":"Madison: Pain Research Group, WHO Collaborating Centre for Symptom Evaluation in Cancer Care;"},{"issue":"2","key":"2021031608590508300_pnz009-B16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejpain.2005.12.008","article-title":"The Pain Self-Efficacy Questionnaire: Taking pain into account","volume":"11","author":"Nicholas","year":"2007","journal-title":"Eur J Pain"},{"issue":"1\u20132","key":"2021031608590508300_pnz009-B17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pain.2007.04.007","article-title":"What do the numbers mean? Normative data in chronic pain measures","volume":"134","author":"Nicholas","year":"2008","journal-title":"Pain"},{"key":"2021031608590508300_pnz009-B18","volume-title":"Measuring Functioning and Well-Being: The Medical Outcomes Study Approach","author":"Stewart","year":"1992"},{"issue":"4","key":"2021031608590508300_pnz009-B19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.genhosppsych.2010.03.006","article-title":"The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: A systematic review","volume":"32","author":"Kroenke","year":"2010","journal-title":"Gen Hosp Psychiatry"},{"issue":"9","key":"2021031608590508300_pnz009-B20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: Validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"10","key":"2021031608590508300_pnz009-B21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: The GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1","key":"2021031608590508300_pnz009-B22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1185\/135525703125002360","article-title":"The Primary Care PTSD screen (PC-PTSD): Development and operating characteristics","volume":"9","author":"Prins","year":"2004","journal-title":"Prim Care Psychiatry"},{"issue":"1","key":"2021031608590508300_pnz009-B23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/10550880802545101","article-title":"The prevalence of childhood trauma among those seeking buprenorphine treatment","volume":"28","author":"Sansone","year":"2009","journal-title":"J Addict Dis"},{"issue":"7","key":"2021031608590508300_pnz009-B24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1080\/00048670902970882","article-title":"2007 National Survey of Mental Health and Wellbeing: Methods and key findings","volume":"43","author":"Slade","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"2021031608590508300_pnz009-B25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/mpr.196","article-title":"Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys","volume":"15","author":"Haro","year":"2006","journal-title":"Int J Methods Psychiatry Res"},{"issue":"2","key":"2021031608590508300_pnz009-B26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mpr.168","article-title":"The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI)","volume":"13","author":"Kessler","year":"2004","journal-title":"Int J Methods Psychiatry Res"},{"issue":"2","key":"2021031608590508300_pnz009-B27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1192\/bjp.bp.107.040113","article-title":"Cross-national prevalence and risk factors for suicidal ideation, plans and attempts","volume":"192","author":"Nock","year":"2008","journal-title":"Br J Psychiatry"},{"issue":"3","key":"2021031608590508300_pnz009-B28","doi-asserted-by":"crossref","DOI":"10.1037\/0021-843X.115.3.616","article-title":"Prevalence of and risk factors for suicide attempts versus suicide gestures: Analysis of the National Comorbidity Survey","volume":"115","author":"Nock","year":"2006","journal-title":"J Abnorm Psychol"},{"key":"2021031608590508300_pnz009-B29","volume-title":"Composite International Diagnostic Interview. Version 3.0","author":"World Health Organization","year":"2001"},{"key":"2021031608590508300_pnz009-B30","author":"Nielsen","year":"2014"},{"issue":"6","key":"2021031608590508300_pnz009-B31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/pds.3945","article-title":"A synthesis of oral morphine equivalents (OME) for opioid utilisation studies","volume":"25","author":"Nielsen","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021031608590508300_pnz009-B32","volume-title":"ATC Index with DDDs","author":"World Health Organization","year":"2003"},{"issue":"2","key":"2021031608590508300_pnz009-B33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"2021031608590508300_pnz009-B34","first-page":"CD008943.","article-title":"Combination pharmacotherapy for the treatment of neuropathic pain in adults","volume":"7","author":"Chaparro","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2021031608590508300_pnz009-B35","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0269216310378546","article-title":"Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: Systematic review","volume":"25","author":"Bennett","year":"2011","journal-title":"Palliat Med"},{"key":"2021031608590508300_pnz009-B36","first-page":"22","article-title":"Are antipsychotic medications suitable for chronic noncancer pain?","author":"Day","year":"2017","journal-title":"Pain Manag Today"},{"key":"2021031608590508300_pnz009-B37","first-page":"CD004844","article-title":"Antipsychotics for acute and chronic pain in adults","volume":"8","author":"Seidel","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2021031608590508300_pnz009-B38","first-page":"CD011804","article-title":"Antipsychotics for fibromyalgia in adults","volume":"6","author":"Walitt","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2021031608590508300_pnz009-B39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1099800416657636","article-title":"Polypharmacy, opioid use, and fibromyalgia: A secondary analysis of clinical trial data","volume":"19","author":"Menzies","year":"2017","journal-title":"Biol Res Nurs"},{"issue":"2","key":"2021031608590508300_pnz009-B40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/pme.12594","article-title":"Benzodiazepine use among chronic pain patients prescribed opioids: Associations with pain, physical and mental health, and health service utilization","volume":"16","author":"Nielsen","year":"2015","journal-title":"Pain Med"},{"key":"2021031608590508300_pnz009-B41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/JPR.S122853","article-title":"Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: Differential in opioid doses","volume":"10","author":"Zin","year":"2017","journal-title":"J Pain Res"},{"issue":"4","key":"2021031608590508300_pnz009-B42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am J Prev Med"},{"key":"2021031608590508300_pnz009-B43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.drugalcdep.2017.05.047","article-title":"Increases from 2002 to 2015 in prescription opioid overdose deaths in combination with other substances","volume":"178","author":"Kandel","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"2021031608590508300_pnz009-B44","article-title":"Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999-2008","author":"Darke","year":"2011","journal-title":"J Forensic Sci"},{"key":"2021031608590508300_pnz009-B45","doi-asserted-by":"crossref","DOI":"10.1111\/dar.12033","article-title":"Trends in fentanyl prescriptions and fentanyl-related mortality in Australia","author":"Roxburgh","year":"2013","journal-title":"Drug Alcohol Rev"},{"key":"2021031608590508300_pnz009-B46","first-page":"CD008165","article-title":"Interventions to improve the appropriate use of polypharmacy for older people","volume":"5","author":"Patterson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2021031608590508300_pnz009-B47","volume-title":"Depression in Adults: Recognition and Management","author":"National Institute for Health and Care Excellence","year":"2018"},{"key":"2021031608590508300_pnz009-B48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/JMDH.S104807","article-title":"Information bias in health research: Definition, pitfalls, and adjustment methods","volume":"9","author":"Althubaiti","year":"2016","journal-title":"J Multidiscip Healthc"},{"issue":"3","key":"2021031608590508300_pnz009-B49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: A review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug Alcohol Depend"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/20\/12\/2450\/36609675\/pnz009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/20\/12\/2450\/36609675\/pnz009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T09:44:32Z","timestamp":1615887872000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/20\/12\/2450\/5376660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,3,12]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnz009","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,3,12]]}}}